Cargando…

Characterization of Structurally Diverse (18)F-Labeled d-TCO Derivatives as a PET Probe for Bioorthogonal Pretargeted Imaging

[Image: see text] Background: The pretargeted imaging strategy using inverse electron demand Diels–Alder (IEDDA) cycloaddition between a trans-cyclooctene (TCO) and tetrazine (Tz) has emerged and rapidly grown as a promising concept to improve radionuclide imaging and therapy in oncology. This strat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adhikari, Karuna, Dewulf, Jonatan, Vangestel, Christel, Van der Veken, Pieter, Stroobants, Sigrid, Elvas, Filipe, Augustyns, Koen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586181/ https://www.ncbi.nlm.nih.gov/pubmed/37867688 http://dx.doi.org/10.1021/acsomega.3c04597

Ejemplares similares

Preclinical Evaluation of a Novel (18)F-Labeled dTCO-Amide Derivative for Bioorthogonal Pretargeted Positron Emission Tomography Imaging
por: Ruivo, Eduardo, et al.
Publicado: (2020)

Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders—An Update
por: Dewulf, Jonatan, et al.
Publicado: (2020)

Immuno-PET Molecular Imaging of RANKL in Cancer
por: Dewulf, Jonatan, et al.
Publicado: (2021)

Site-specific (68)Ga-labeled nanobody for PET imaging of CD70 expression in preclinical tumor models
por: Dewulf, Jonatan, et al.
Publicado: (2023)

Direct Cu-mediated aromatic (18)F-labeling of highly reactive tetrazines for pretargeted bioorthogonal PET imaging
por: García-Vázquez, Rocío, et al.
Publicado: (2021)

(18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels–Alder Click Chemistry
por: Meyer, Jan-Philip, et al.
Publicado: (2015)

Pretargeted Imaging and Radioimmunotherapy of Cancer Using Antibodies and Bioorthogonal Chemistry
por: van de Watering, Floor C. J., et al.
Publicado: (2014)

Molecular Imaging of Apoptosis: The Case of Caspase-3 Radiotracers
por: Beroske, Lucas, et al.
Publicado: (2021)

Characterization of [(99m)Tc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis
por: Elvas, Filipe, et al.
Publicado: (2015)

Improved Characteristics of RANKL Immuno-PET Imaging Using Radiolabeled Antibody Fab Fragments
por: Dewulf, Jonatan, et al.
Publicado: (2022)

Tetrazine Carbon Nanotubes for Pretargeted In Vivo “Click‐to‐Release” Bioorthogonal Tumour Imaging
por: Li, He, et al.
Publicado: (2020)

Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept
por: Rondon, Aurélie, et al.
Publicado: (2019)

Bioorthogonally Applicable Fluorescence Deactivation Strategy for Receptor Kinetics Study and Theranostic Pretargeting Approaches
por: van der Wal, Steffen, et al.
Publicado: (2018)

Lipophilicity and Click Reactivity Determine the Performance of Bioorthogonal Tetrazine Tools in Pretargeted In Vivo Chemistry
por: Stéen, E. Johanna L., et al.
Publicado: (2021)

Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [(89)Zr]Zr-DFO-PEG(5)-Tz
por: Lumen, Dave, et al.
Publicado: (2022)

First-in-human study of a novel cell death tracer [(99m)Tc]Tc-Duramycin: safety, biodistribution and radiation dosimetry in healthy volunteers
por: Metelerkamp Cappenberg, Taco, et al.
Publicado: (2023)

Antibody PEGylation in bioorthogonal pretargeting with trans-cyclooctene/tetrazine cycloaddition: in vitro and in vivo evaluation in colorectal cancer models
por: Rondon, Aurélie, et al.
Publicado: (2017)

Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA(5m) chelators
por: Moon, Euy Sung, et al.
Publicado: (2020)

ATG4B Inhibitor UAMC-2526 Potentiates the Chemotherapeutic Effect of Gemcitabine in a Panc02 Mouse Model of Pancreatic Ductal Adenocarcinoma
por: Takhsha, Farnaz Sedigheh, et al.
Publicado: (2021)

Development of (18)F-Labeled Bispyridyl Tetrazines for In Vivo Pretargeted PET Imaging
por: García-Vázquez, Rocío, et al.
Publicado: (2022)

A pretargeting system for tumor PET imaging and radioimmunotherapy
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2015)

Antibody-Based In Vivo Imaging of Central Nervous System Targets—Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines
por: Bredack, Christoph, et al.
Publicado: (2022)

How to Modulate Tumor Hypoxia for Preclinical In Vivo Imaging Research
por: De Bruycker, Sven, et al.
Publicado: (2018)

In Vivo Amyloid-β Imaging in the APPPS1–21 Transgenic Mouse Model with a (89)Zr-Labeled Monoclonal Antibody
por: Waldron, Ann-Marie, et al.
Publicado: (2016)

Conformationally Strained trans-Cyclooctene (sTCO) Enables the Rapid Construction of (18)F-PET Probes via Tetrazine Ligation
por: Wang, Mengzhe, et al.
Publicado: (2016)

In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes
por: Van Rymenant, Yentl, et al.
Publicado: (2021)

Design of Fluorescent Probes for Bioorthogonal Labeling of Carbonylation in Live Cells
por: Erkan, Hazel, et al.
Publicado: (2020)

Probing the Mycobacterial Trehalome with Bioorthogonal Chemistry
por: Swarts, Benjamin M., et al.
Publicado: (2012)

A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer
por: Adumeau, Pierre, et al.
Publicado: (2016)

Adamantane/Cucurbituril: A Potential Pretargeted Imaging Strategy in Immuno-PET
por: Strebl, Martin G., et al.
Publicado: (2018)

Pretargeted PET Imaging of trans-Cyclooctene-Modified Porous Silicon Nanoparticles
por: Keinänen, Outi, et al.
Publicado: (2017)

Effects of metformin on tumor hypoxia and radiotherapy efficacy: a [(18)F]HX4 PET imaging study in colorectal cancer xenografts
por: De Bruycker, Sven, et al.
Publicado: (2019)

Therapeutic Applications of Pretargeting
por: Verhoeven, Marjolein, et al.
Publicado: (2019)

Comparative Evaluation of Novel (177)Lu-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting
por: Tano, Hanna, et al.
Publicado: (2021)

Evaluation of a (68)Ga-Labeled DOTA-Tetrazine as a PET Alternative to (111)In-SPECT Pretargeted Imaging
por: Edem, Patricia E., et al.
Publicado: (2020)

Pretargeted Molecular Imaging and Radioimmunotherapy
por: Goldenberg, David M., et al.
Publicado: (2012)

Improvement of Radioimmunotherapy Using Pretargeting
por: Frampas, Eric, et al.
Publicado: (2013)

Photoreactive bioorthogonal lipid probes and their applications in mammalian biology
por: Shanbhag, Karthik, et al.
Publicado: (2022)

Selective bioorthogonal probe for N-glycan hybrid structures
por: Mukherjee, Mana Mohan, et al.
Publicado: (2023)

Early Changes in [(18)F]FDG Uptake as a Readout for PI3K/Akt/mTOR Targeted Drugs in HER-2-Positive Cancer Xenografts
por: Dockx, Yanina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fshgmcc3v534l1hcn2cgq3ag7r